Prevalence of Dyslipidemia in Young Adult Indian Population
AM Sawant, Dhanashri Shetty, R Mankeshwar, Tester F Ashavaid*
Background: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in our society with dyslipidemia contributing significantly to atherosclerosis. Thus measurement of plasma lipids would help in identifying people at risk for CVD. The goal of this study was to ascertain the prevalence of Dyslipidemia among young adult population in urban India.
Material and Methods : The study was conducted for a period of one year – from 1st January 2006 to 31st December 2006. Around 1805 subjects with ³ 40 age group were selected from a population of approximately 9000 urban dwellers who had attended annual general health check ups in P. D. Hinduja National Hospital and Medical research Center. Health status was evaluated by physical check ups, complete fasting lipid profiles and blood glucose levels. Dyslipidemia risk and impaired blood sugar levels were determined as per National Cholesterol Education Program (NCEP) – Adult Treatment Panel (ATP) III guidelines and American Diabetes Association (ADA) respectively.
Results: The prevalence of dyslipidemia was observed to be higher in males then in females. Among participants who had a total Cholesterol (TC) concentration ³ 200mg/dl, 38.7% were males and 23.3% were females. High density lipoprotein cholesterol (HDL-C) was abnormally low in 64.2% males and 33.8% in females. The increase of prevalence of hypercholesterolemia and hypertriglyceridemia was more prominent in 31-40 age group than in £ 30 age group.
Conclusion: The low percentage of adults with controlled lipid concentrations suggests that there is a need for awareness programs for the prevention and control of Dyslipidemia and impaired blood sugar levels. ©
Cardiovascular diseases (CVD) are the most prevalent cause of death and disability in both developed as well as developing countries.1 South Asians around the globe have the highest rates of Coronary Artery Disease (CAD).2 According to National Commission on Macroeconomics and Health (NCMH), a government of India undertaking, there would be around 62 million patients with CAD by 2015 in India and of these, 23 million would be patients younger than 40 years of age.3 CAD is usually due to atherosclerosis of large and medium sized arteries and Dyslipidemia has been found to be one of the most important contributing factor.4 As it has long been known that lipid abnormalities are major risk factors for premature CAD,6,2 studies on the prevalence of these risk factors are urgently needed. In this retrospective study, we report the prevalence of dyslipidemia in young adult Indian population.
Material and Methods
Design and Data Collection
The study population consisted of 8967 members who attended Health check-up program from January - December 2006 at P. D. Hinduja National Hospital and Medical Research Center, Mumbai, India. Of these, around 1805 healthy individuals were selected from the Medical database which included, demographics (age, gender), anthropometric measurements (relative body weight, height), lifestyle related factors (smoking status, alcohol consumption, diet and physical activity) and clinical findings (hypertension, diabetes, ischemic heart disease, medication profile and family history). Blood samples were collected by venipuncture after an overnight fast for 12-14 hours. Venous blood was collected in plain and fluoride bulbs for measurement of serum lipids and glucose respectively.
Serum Lipid and Glucose Analysis
The analysis was carried on an automated clinical chemistry analyzer; Beckman Synchron Lx20. Serum glucose was measured by oxygen rate method employing a Beckman oxygen electrode (glucose oxidase). TC, low density lipoprotein cholesterol (LDL-C), HDL-C and triglyceride (TG) concentrations were measured by International Federation of Clinical Chemistry (IFCC) approved enzymatic methods. Beckman reagents and calibrators were used for the analysis. HDL-N and LDL-N are directly estimated by ready to use stable liquid reagents. Control sera were included in each batch of samples analyzed. As a part of external quality assurance, our laboratory is enrolled with the proficiency testing surveys of the College of American (CAP) Pathologists and is the first hospital lab in India to be CAP accredited.
Defenitions and Preferred Cutoff Values
For serum lipids, we referred to NCEP - ATP III Guidelines.4,5 According to these standard guidelines, hypercholesterolemia is defined as TC >200mg/dl, LDL-C as >100mg/dl, hypertriglyceridemia as TG >150mg/dl and HDL-C <40mg/dl. Dyslipidemia is defined by presence of one or more than one abnormal serum lipid concentration. For serum Glucose levels, we referred to ADA Guidelines.7 Persons with fasting blood glucose >126mg/dl or who were on medication for diabetes was considered as having diabetes mellitus.
The statistical analysis was performed using the SPSS (version 13.0). Lipid and glucose levels were expressed as the mean ± SD. The data was further categorized according to age group and gender. The normality of the data was checked by the Shapiro-Wilk procedure. As the underlying data distribution is non-normal, Mann Whitney U test was applied to test the relationship of independent and dependent variables. Pearson’s chi square test was applied in comparisons of independent and dependent proportions. Odds ratio (OR) and 95% confidence interval (CI) was calculated to find out the significance of the data. A p value <0.05 was considered deemed significant. Prevalence of dyslipidemia by means of its determinants was calculated using the prevalence rate formula: number of patients per total number of all subjects at the time of study multiplied by 100. Results were expressed as percentages.
The study population was comprised of 1805 subjects that included 1128 males and 677 females (Fig. 1) and the clinical features of the subjects are shown in (Table 1). On applying NCEP and ADA guidelines we found out that nearly 80% of the subjects had atleast one abnormal parameter.
Increased levels of fasting and postprandial blood glucose, hypercholesterolemia, hypertriglyceridemia and increased levels of LDL-C were found to be more in males. Similarly decreased HDL-C levels were again found to be more in males (Table 2).
On further comparing between males and females according to age we found significantly increased levels of fasting blood glucose, postprandial blood glucose, hypercholesterolemia, hypertriglyceridemia, low HDL, and high LDL to be in 31-40 year old males and females than in £ 30 year old males and females. There were no significant differences in low HDL concentration between age groups in males and females (Figs. 2 and 3).
The Figure 4 shows specific prevalence of dyslipidemia and impaired blood glucose levels according to gender. The prevalence of elevated fasting and postprandial blood glucose, hypercholesterolemia, hypertriglyceridemia, low HDL, and high LDL were significantly higher in males than in females (34.1% vs. 22.1%, 13.2% vs. 8.1%, 38.6% vs. 23.3%, 42.6% vs. 17.2%, 64.2% vs 33.8%, 74.3% vs. 61.2%) respectively.
This study is a step towards evaluating the lipids and lipoprotiens and glucose levels in health urban Indian population. The study reveals the prevalence of hypercholesterolemia, hypertriglyceridemia and abnormally high LDL-C and low HDL-C levels which are well-known risk factors for cardiovascular diseases in all age groups. Our results are consistent with the previous cross-sectional study conducted among selected industrial population wherein increased prevalence of dyslipidemia in young adults was found to be one of the major contributors of CVD.6 Increased prevalence of high fasting glucose and serum lipids were more prominent in 31 – 40 age group as compared to £ 30 years which means the risk of dyslipidemia increases as the age advances. In our study we observed, both fasting and postprandial impaired glucose levels to be more in 31-40 age group males and of these 7% were found to be actually diabetic i.e. they were either on some medication or were newly diagnosed. This means the remaining subjects with impaired blood glucose levels are on their way to develop diabetes, which is an important risk factor for CAD. Enas et al. in Coronary artery disease in Indians (CADI) study reports the prevalence of diabetes to be three to six times higher among south Asian’s than Europeans, Americans and other Asians.2
The high prevalence of hypercholesterolemia, hypertriglyceridemia and low HDL, in our 31-40 years age group is a major cause of concern. It has been observed that in comparison with western population, a relatively lower level of cholesterol appears to predispose Indians to CAD.7 Also in a Chennai based hospital study, it was shown that around 75% of patients with myocardial infarction (MI) had TC levels <200mg/dl indicating that the threshold for the TC levels above which it posses a risk for CAD is low in Indians.8 The crude prevalence of hypertriglyceridemia differs between the age groups and it was higher in men than in women. The contributing factor for hypertriglyceridemia in our population could be our diet rich in carbohydrates.9 High TG levels have been associated with increased levels of small dense LDL which are considered to be highly atherogenic.10 Increased prevalence of low HDL has been reported earlier by Enas etal. who found that only 4% of Asian Indian men and 5% Asian Indian women had optimal HDL levels.11
Low HDL-C levels are stronger predictor of occurrence and reoccurrence of MI and stroke and are also associated with premature and severe CAD.12 Oxidative modification of LDL-C is a key process of atherosclerosis and elevated LDL-C has been recognized as primary risk factor for CAD by NCEP – ATPIII.13 In our study increased LDL-C has been found to be contributing majorly to dyslipidemia irrespective of age and gender. On comparing the prevalence of dyslipidemia and impaired blood glucose (IBG) levels between males and females, we observed it to be higher in males suggesting this group at higher risk of dyslipidemia, which in turn can lead to increased risk of developing CAD.
Comparing our data with a Turkish study conducted on similar lines, lead to the observation that in both the studies, prevalence of dyslipidemia was more in males but the percentage prevalence in our population was higher indicating Indians being at higher risk.14 Diet with high fat and calorie intake and lack of physical activity would be the major culprits of dyslipidemia in our population. References have shown that our diets are rich in saturated fats. Besides it also involves overcooking of food which results in destruction of nutrients like folate, deep frying and refrying in the same oil leading to trans fatty acids formation which probably contributes to increase of Dyslipidemia in our population.15 The influence of diet on Dyslipidemia was best seen in the Canadian study wherein 3 groups: a control group, a group that was administered statin and a group with dietary modification was included. The lipid levels were checked at baseline and again after 4 weeks. A drastic reduction in lipid levels was observed in statin and dietary modified groups as compared to control group. However, between the two they did not vary much.16 This means therapeutic intervention i.e. statin and dietary interventions seems to have the same effect, and the latter seems to be a more viable option.
This study revealed the increased prevalence of dyslipidemia to be more prevalent in 31-40 year males, suggesting that this group is at increased risk of developing CAD leading to young infarcts. Combination lifestyle therapies i.e., enhanced physical activity and dietary modification and therapeutic intervention17,18 would help us in treatment and management of dyslipidemia.
We acknowledge the support and help provided by the Medical Record Department of P. D. Hinduja National Hospital and Medical Research Center, Mahim, Mumbai.
1. Chaturvedi V, Bhargava B. Health Care Delivery for Coronary Heart Disease in India- Where are we Headed. Am Heart Hosp J 2007;5:32-37.
2. Enas EA, Chacko V, Pazhoor SG, Chennikkara H and Devarapalli P. Dyslipidemia in South Asian Patients. Current Atherosclerosis Reports 2007;9:367-74.
3. Indrayan A. Forecasting vascular disease cases and associated mortality in India. Reports of the National Commission on Macroeconomics and Health. Ministry of Health and Family Welfare, India 2005. Available at: http://www.whoindia.org/EN/Section102/Section201_888.htm. Accessed November 2, 2006.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [special communication]. JAMA 2001;285:2486-2947.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report [special communication]. Circulation 2002;106: 3143-3421.
6. Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L, Mohan BVM, Pandav CS, Ahmed FU, Meera R, Joshi PP, Amin RB, Ahuja RC, Das MS, and Jaison TM. Methods for establishing a surveillance system for cardiovascular disease in Indian industrial populations. Bulletin of the World Health Organization 2006;84:461-69.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1): S43-48. Available at: http://www.diabetes.org/diabetes-prevention/pre-diabetes.jsp
8. Kumar S, Roy S. Tropical Heart Disease in India. In: Mantosh Panja editors. Dyslipidemia in Indians. Mumbai. Indian College of Physicians 2005;109-18.
9. Krishnaswami V, Radhakrishnan T, John BV, and Mathew A. Pattern of ischaemic heart disease: a clinical study. J Indian Med Asso 1970;55:153-57.
10. Enas EA, Senthilkumar A, Chennikkara H, and Bjurlin MA. Prudent Diet and Preventive nutrition from Pediatrics to Geriatrics: Current Knowledge and Practical recommendations. Indian Heart J 2003;55:310-38.
11. Mora S, Szklo M, and Otwos JD. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007;192:211-17.
12. Enas EA, Yusuf S, and Mehta JL. Prevalence of Coronary Artery Disease in Asian- Indians. Am J Cardiol 1992;70:945-49.
13. Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, and Gordis L. The association of low levels of HDL cholesterol and arteriography defined coronary artery disease. Am J Epidermiol 1979;109:285-95.
14. Soysal A, Demiral Y, Soysal D, Ucku R, Koseoglu M, Aksakoglu G. The prevalence of metabolic syndrome among ypung adults in Izmir, Turkey. Anadolu Kardiyol Derg 2005;5:196-201.
15. Enas AE, Senthilkumar A, Hancy C, and Marc AB. Prudent diet and preventive nutrition from pediatrics to geriatrics: current knowledge and practical recommendations. Indian Heart J 2003;55:310-38.
16. David JAJ, Cyril WCK,
Augustine M, Dorothea AF, Julia MWW, Russell D, Azadeh E, Tina LP, Edward V,
Karen GL, Elke aT, Robert GJ, Lawrence AL and Philip WC. Effects
of a dietary portfolio of cholesterol – lowering foods vs lovastatin on serum
lipids and C-reactive protein. JAMA 2003;290:
17. Mc-Carron DA, Reusser ME. Reducing Cardiovascular Disease Risk with Diet. Obesity Research 2001;9(suppl.4):335s-340s.
18. Jenkins DJA, Kendall CWC, Marchie A, Faulkner D, Wong JMW, DeSouza R, Emam A, Parker T, Vidgen E, Lapsley KG, Trautwein EA, Josse RG, Leiter LA, and Connelly PW. Effects of a Dietary portfolio of Cholesterol- Lowering foods vs Lovastain on serum lipids and C- reactive protein. JAMA 2003;290:502-10.